Syndrome of inappropriate antidiuretic hormone associated with aripiprazole
PURPOSEA probable case of aripiprazole-induced syndrome of inappropriate antidiuretic hormone (SIADH) is reported. SUMMARYA 65-year-old Caucasian man arrived in the emergency department (ED) with dizziness, headache, abdominal pain, nausea, and vomiting. There had been no recent additions or changes...
Gespeichert in:
Veröffentlicht in: | American journal of health-system pharmacy 2013-12, Vol.70 (23), p.2110-2114 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2114 |
---|---|
container_issue | 23 |
container_start_page | 2110 |
container_title | American journal of health-system pharmacy |
container_volume | 70 |
creator | YAM, FELIX K JACKSON, ELIZABETH A KWAN, BRIAN K |
description | PURPOSEA probable case of aripiprazole-induced syndrome of inappropriate antidiuretic hormone (SIADH) is reported.
SUMMARYA 65-year-old Caucasian man arrived in the emergency department (ED) with dizziness, headache, abdominal pain, nausea, and vomiting. There had been no recent additions or changes to the patientʼs medication regimen except for an increase in the daily dose of aripiprazole (from 10 to 20 mg) about two months prior. On admission, the patientʼs serum sodium concentration was 108 meq/L, prompting discontinuation of aripiprazole use and fluid restrictions. Over the next 72 hours, the serum sodium level increased to a near-normal concentration (127 meq/L), and the man was discharged back to a nursing facility. Three days later, the patient was readmitted to the ED with recurrent symptoms and a serum sodium concentration of 118 meq/L, a serum osmolality of 254 mOsm/kg, a urine osmolality of 575 mOsm/kg, and a urine sodium concentration of 101 meq/L. It was learned that aripiprazole use had been inappropriately resumed at the nursing facility. Aripiprazole was again discontinued, and fluid restrictions were imposed, with subsequent abatement of hyponatremia over four days. Application of the adverse drug reaction probability scale of Naranjo et al. in this case yielded a score of 7, indicating probable aripiprazole-associated SIADH.
CONCLUSIONA 65-year-old man developed severe hyponatremia after an aripiprazole dosage increase. Hyponatremia resolved promptly with the discontinuation of aripiprazole. After discharge from the hospital, the patient inadvertently received aripiprazole again and was subsequently readmitted with another episode of severe hyponatremia. |
doi_str_mv | 10.2146/ajhp130142 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1459974668</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A356267712</galeid><sourcerecordid>A356267712</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4619-c04be8697961b6db7a2ae104e9d397722559255f7f816d5c35ef5fc9481ed4fd3</originalsourceid><addsrcrecordid>eNptkVuL1TAUhYsozjj64g-QggyK0DFJc2keh8EbDvigPoecdGeaMW1q0lLGX-8-nKODICHZYedbYSWrqp5TcsEol2_t7TDTllDOHlSnVLSiYZqQh7gnSjeMdOykelLKLSGUdUQ-rk4YZ1wrSU-rz1_vpj6nEerk6zDZec5pzsEuUNtpCX1YMyzB1UPKY5qwWUpy--O-3sIy1DaHOczZ_koRnlaPvI0Fnh3rWfX9_btvVx-b6y8fPl1dXjeOS6obR_gOOqmVlnQn-52yzAIlHHTfaqUYE0Lj9Mp3VPbCtQK88E7zjkLPfd-eVa8P96LXnyuUxYyhOIjRTpDWYigXWisuZYfoywN6YyOYMPm0ZOv2uLlshWRSKcqQuvgPhaOHMTh8tg_Y_0fw5iBwOZWSwRv8s9HmO0OJ2Wdi7jNB-MXR7robof-L_gkBgfMjYIuz0Wc7uVDuuQ6Dk0Igxw_cluICufyI6wbZDGDjMhhCCG8lUxg4bSkupMEW1Sh7dZAN4WbYQgZTRhsjumFm2zaFjls0TUn7G0rDsAU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1459974668</pqid></control><display><type>article</type><title>Syndrome of inappropriate antidiuretic hormone associated with aripiprazole</title><source>MEDLINE</source><source>Oxford University Press Journals Current</source><source>Journals@Ovid Complete</source><creator>YAM, FELIX K ; JACKSON, ELIZABETH A ; KWAN, BRIAN K</creator><creatorcontrib>YAM, FELIX K ; JACKSON, ELIZABETH A ; KWAN, BRIAN K</creatorcontrib><description>PURPOSEA probable case of aripiprazole-induced syndrome of inappropriate antidiuretic hormone (SIADH) is reported.
SUMMARYA 65-year-old Caucasian man arrived in the emergency department (ED) with dizziness, headache, abdominal pain, nausea, and vomiting. There had been no recent additions or changes to the patientʼs medication regimen except for an increase in the daily dose of aripiprazole (from 10 to 20 mg) about two months prior. On admission, the patientʼs serum sodium concentration was 108 meq/L, prompting discontinuation of aripiprazole use and fluid restrictions. Over the next 72 hours, the serum sodium level increased to a near-normal concentration (127 meq/L), and the man was discharged back to a nursing facility. Three days later, the patient was readmitted to the ED with recurrent symptoms and a serum sodium concentration of 118 meq/L, a serum osmolality of 254 mOsm/kg, a urine osmolality of 575 mOsm/kg, and a urine sodium concentration of 101 meq/L. It was learned that aripiprazole use had been inappropriately resumed at the nursing facility. Aripiprazole was again discontinued, and fluid restrictions were imposed, with subsequent abatement of hyponatremia over four days. Application of the adverse drug reaction probability scale of Naranjo et al. in this case yielded a score of 7, indicating probable aripiprazole-associated SIADH.
CONCLUSIONA 65-year-old man developed severe hyponatremia after an aripiprazole dosage increase. Hyponatremia resolved promptly with the discontinuation of aripiprazole. After discharge from the hospital, the patient inadvertently received aripiprazole again and was subsequently readmitted with another episode of severe hyponatremia.</description><identifier>ISSN: 1079-2082</identifier><identifier>EISSN: 1535-2900</identifier><identifier>DOI: 10.2146/ajhp130142</identifier><identifier>PMID: 24249761</identifier><language>eng</language><publisher>Bethesda, MD: American Society of Health-System Pharmacists</publisher><subject>Adverse and side effects ; Aged ; Antipsychotic Agents - administration & dosage ; Antipsychotic Agents - adverse effects ; Aripiprazole ; Biological and medical sciences ; Case studies ; Complications and side effects ; Dose-Response Relationship, Drug ; Drug toxicity and drugs side effects treatment ; Drugs ; Hospitalization ; Humans ; Hyponatremia ; Inappropriate ADH Syndrome - chemically induced ; Inappropriate ADH Syndrome - physiopathology ; Male ; Medical sciences ; Miscellaneous (drug allergy, mutagens, teratogens...) ; Pharmacology. Drug treatments ; Piperazines - administration & dosage ; Piperazines - adverse effects ; Quinolones - administration & dosage ; Quinolones - adverse effects ; Severity of Illness Index</subject><ispartof>American journal of health-system pharmacy, 2013-12, Vol.70 (23), p.2110-2114</ispartof><rights>Copyright © 2013 American Society of Health-System Pharmacists, Inc. All rights reserved.</rights><rights>2015 INIST-CNRS</rights><rights>COPYRIGHT 2013 Oxford University Press</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4619-c04be8697961b6db7a2ae104e9d397722559255f7f816d5c35ef5fc9481ed4fd3</citedby><cites>FETCH-LOGICAL-c4619-c04be8697961b6db7a2ae104e9d397722559255f7f816d5c35ef5fc9481ed4fd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28001655$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24249761$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>YAM, FELIX K</creatorcontrib><creatorcontrib>JACKSON, ELIZABETH A</creatorcontrib><creatorcontrib>KWAN, BRIAN K</creatorcontrib><title>Syndrome of inappropriate antidiuretic hormone associated with aripiprazole</title><title>American journal of health-system pharmacy</title><addtitle>Am J Health Syst Pharm</addtitle><description>PURPOSEA probable case of aripiprazole-induced syndrome of inappropriate antidiuretic hormone (SIADH) is reported.
SUMMARYA 65-year-old Caucasian man arrived in the emergency department (ED) with dizziness, headache, abdominal pain, nausea, and vomiting. There had been no recent additions or changes to the patientʼs medication regimen except for an increase in the daily dose of aripiprazole (from 10 to 20 mg) about two months prior. On admission, the patientʼs serum sodium concentration was 108 meq/L, prompting discontinuation of aripiprazole use and fluid restrictions. Over the next 72 hours, the serum sodium level increased to a near-normal concentration (127 meq/L), and the man was discharged back to a nursing facility. Three days later, the patient was readmitted to the ED with recurrent symptoms and a serum sodium concentration of 118 meq/L, a serum osmolality of 254 mOsm/kg, a urine osmolality of 575 mOsm/kg, and a urine sodium concentration of 101 meq/L. It was learned that aripiprazole use had been inappropriately resumed at the nursing facility. Aripiprazole was again discontinued, and fluid restrictions were imposed, with subsequent abatement of hyponatremia over four days. Application of the adverse drug reaction probability scale of Naranjo et al. in this case yielded a score of 7, indicating probable aripiprazole-associated SIADH.
CONCLUSIONA 65-year-old man developed severe hyponatremia after an aripiprazole dosage increase. Hyponatremia resolved promptly with the discontinuation of aripiprazole. After discharge from the hospital, the patient inadvertently received aripiprazole again and was subsequently readmitted with another episode of severe hyponatremia.</description><subject>Adverse and side effects</subject><subject>Aged</subject><subject>Antipsychotic Agents - administration & dosage</subject><subject>Antipsychotic Agents - adverse effects</subject><subject>Aripiprazole</subject><subject>Biological and medical sciences</subject><subject>Case studies</subject><subject>Complications and side effects</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Drugs</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Hyponatremia</subject><subject>Inappropriate ADH Syndrome - chemically induced</subject><subject>Inappropriate ADH Syndrome - physiopathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Miscellaneous (drug allergy, mutagens, teratogens...)</subject><subject>Pharmacology. Drug treatments</subject><subject>Piperazines - administration & dosage</subject><subject>Piperazines - adverse effects</subject><subject>Quinolones - administration & dosage</subject><subject>Quinolones - adverse effects</subject><subject>Severity of Illness Index</subject><issn>1079-2082</issn><issn>1535-2900</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkVuL1TAUhYsozjj64g-QggyK0DFJc2keh8EbDvigPoecdGeaMW1q0lLGX-8-nKODICHZYedbYSWrqp5TcsEol2_t7TDTllDOHlSnVLSiYZqQh7gnSjeMdOykelLKLSGUdUQ-rk4YZ1wrSU-rz1_vpj6nEerk6zDZec5pzsEuUNtpCX1YMyzB1UPKY5qwWUpy--O-3sIy1DaHOczZ_koRnlaPvI0Fnh3rWfX9_btvVx-b6y8fPl1dXjeOS6obR_gOOqmVlnQn-52yzAIlHHTfaqUYE0Lj9Mp3VPbCtQK88E7zjkLPfd-eVa8P96LXnyuUxYyhOIjRTpDWYigXWisuZYfoywN6YyOYMPm0ZOv2uLlshWRSKcqQuvgPhaOHMTh8tg_Y_0fw5iBwOZWSwRv8s9HmO0OJ2Wdi7jNB-MXR7robof-L_gkBgfMjYIuz0Wc7uVDuuQ6Dk0Igxw_cluICufyI6wbZDGDjMhhCCG8lUxg4bSkupMEW1Sh7dZAN4WbYQgZTRhsjumFm2zaFjls0TUn7G0rDsAU</recordid><startdate>20131201</startdate><enddate>20131201</enddate><creator>YAM, FELIX K</creator><creator>JACKSON, ELIZABETH A</creator><creator>KWAN, BRIAN K</creator><general>American Society of Health-System Pharmacists</general><general>Copyright American Society of Health-System Pharmacists, Inc. All rights reserved</general><general>American Society of Health Pharmacists</general><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20131201</creationdate><title>Syndrome of inappropriate antidiuretic hormone associated with aripiprazole</title><author>YAM, FELIX K ; JACKSON, ELIZABETH A ; KWAN, BRIAN K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4619-c04be8697961b6db7a2ae104e9d397722559255f7f816d5c35ef5fc9481ed4fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adverse and side effects</topic><topic>Aged</topic><topic>Antipsychotic Agents - administration & dosage</topic><topic>Antipsychotic Agents - adverse effects</topic><topic>Aripiprazole</topic><topic>Biological and medical sciences</topic><topic>Case studies</topic><topic>Complications and side effects</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Drugs</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Hyponatremia</topic><topic>Inappropriate ADH Syndrome - chemically induced</topic><topic>Inappropriate ADH Syndrome - physiopathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Miscellaneous (drug allergy, mutagens, teratogens...)</topic><topic>Pharmacology. Drug treatments</topic><topic>Piperazines - administration & dosage</topic><topic>Piperazines - adverse effects</topic><topic>Quinolones - administration & dosage</topic><topic>Quinolones - adverse effects</topic><topic>Severity of Illness Index</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>YAM, FELIX K</creatorcontrib><creatorcontrib>JACKSON, ELIZABETH A</creatorcontrib><creatorcontrib>KWAN, BRIAN K</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of health-system pharmacy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>YAM, FELIX K</au><au>JACKSON, ELIZABETH A</au><au>KWAN, BRIAN K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Syndrome of inappropriate antidiuretic hormone associated with aripiprazole</atitle><jtitle>American journal of health-system pharmacy</jtitle><addtitle>Am J Health Syst Pharm</addtitle><date>2013-12-01</date><risdate>2013</risdate><volume>70</volume><issue>23</issue><spage>2110</spage><epage>2114</epage><pages>2110-2114</pages><issn>1079-2082</issn><eissn>1535-2900</eissn><abstract>PURPOSEA probable case of aripiprazole-induced syndrome of inappropriate antidiuretic hormone (SIADH) is reported.
SUMMARYA 65-year-old Caucasian man arrived in the emergency department (ED) with dizziness, headache, abdominal pain, nausea, and vomiting. There had been no recent additions or changes to the patientʼs medication regimen except for an increase in the daily dose of aripiprazole (from 10 to 20 mg) about two months prior. On admission, the patientʼs serum sodium concentration was 108 meq/L, prompting discontinuation of aripiprazole use and fluid restrictions. Over the next 72 hours, the serum sodium level increased to a near-normal concentration (127 meq/L), and the man was discharged back to a nursing facility. Three days later, the patient was readmitted to the ED with recurrent symptoms and a serum sodium concentration of 118 meq/L, a serum osmolality of 254 mOsm/kg, a urine osmolality of 575 mOsm/kg, and a urine sodium concentration of 101 meq/L. It was learned that aripiprazole use had been inappropriately resumed at the nursing facility. Aripiprazole was again discontinued, and fluid restrictions were imposed, with subsequent abatement of hyponatremia over four days. Application of the adverse drug reaction probability scale of Naranjo et al. in this case yielded a score of 7, indicating probable aripiprazole-associated SIADH.
CONCLUSIONA 65-year-old man developed severe hyponatremia after an aripiprazole dosage increase. Hyponatremia resolved promptly with the discontinuation of aripiprazole. After discharge from the hospital, the patient inadvertently received aripiprazole again and was subsequently readmitted with another episode of severe hyponatremia.</abstract><cop>Bethesda, MD</cop><pub>American Society of Health-System Pharmacists</pub><pmid>24249761</pmid><doi>10.2146/ajhp130142</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1079-2082 |
ispartof | American journal of health-system pharmacy, 2013-12, Vol.70 (23), p.2110-2114 |
issn | 1079-2082 1535-2900 |
language | eng |
recordid | cdi_proquest_miscellaneous_1459974668 |
source | MEDLINE; Oxford University Press Journals Current; Journals@Ovid Complete |
subjects | Adverse and side effects Aged Antipsychotic Agents - administration & dosage Antipsychotic Agents - adverse effects Aripiprazole Biological and medical sciences Case studies Complications and side effects Dose-Response Relationship, Drug Drug toxicity and drugs side effects treatment Drugs Hospitalization Humans Hyponatremia Inappropriate ADH Syndrome - chemically induced Inappropriate ADH Syndrome - physiopathology Male Medical sciences Miscellaneous (drug allergy, mutagens, teratogens...) Pharmacology. Drug treatments Piperazines - administration & dosage Piperazines - adverse effects Quinolones - administration & dosage Quinolones - adverse effects Severity of Illness Index |
title | Syndrome of inappropriate antidiuretic hormone associated with aripiprazole |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T13%3A16%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Syndrome%20of%20inappropriate%20antidiuretic%20hormone%20associated%20with%20aripiprazole&rft.jtitle=American%20journal%20of%20health-system%20pharmacy&rft.au=YAM,%20FELIX%20K&rft.date=2013-12-01&rft.volume=70&rft.issue=23&rft.spage=2110&rft.epage=2114&rft.pages=2110-2114&rft.issn=1079-2082&rft.eissn=1535-2900&rft_id=info:doi/10.2146/ajhp130142&rft_dat=%3Cgale_proqu%3EA356267712%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1459974668&rft_id=info:pmid/24249761&rft_galeid=A356267712&rfr_iscdi=true |